Blood monocytes are collected through apheresis and activated into killer cells.

Cell Therapies Pty Ltd has been set up to manage the commercial interface to the CPC. Cell Therapies Pty Ltd. provides clients and collaborators with a focused business unit that is able to negotiate and execute all business aspects of contract engagements. We are able to provide access to the hospital’s wider expertise in advanced imaging, clinical trial design and approval, recruitment of principal investigators and patients, licensed manufacture, audit compliance, clinical interpretation, and reporting. We build on our experience in protocol development and SOP preparation, while matching research imperatives to licensed production restraints.
Special laboratory features |

By having a CPC within our centre, we can provide ongoing physician input into the CT trial design, ongoing contact with regional clinician colleagues, and closer contact to the patient, hence a higher likelihood of achieving trial recruitment targets. Our academic institute brings substantial expertise in fundamental research to any clinical trial, and therefore the potential to add value to research collaborations. Examples include involvement of the Stem Cell Research and Cancer Immunology Laboratories and the advanced imaging department. The latter has been involved in studies tracking the fate of infused cells
Why Cell Therapies? |